|
End-of-day quote
Shenzhen S.E.
2026-08-14
|
5-day change | 1st Jan Change | ||
| 5.030 CNY | +1.21% |
|
+6.12% | -3.64% |
| Market Cap | 7.18B 1.06B 919M 864M 786M 1.48B 102B 1.5B 10.12B 3.96B 50.96B 4B 3.91B 169B | P/E 2024 |
18.2x | P/E 2025 | 29x |
|---|---|---|---|---|---|
| Enterprise Value | 5.69B 843M 728M 684M 622M 1.17B 80.64B 1.19B 8.02B 3.14B 40.38B 3.17B 3.1B 134B | EV / Sales 2024 |
0.62x | EV / Sales 2025 | 0.84x |
| Free-Float |
39.51% | Yield 2024 |
1.9% | Yield 2025 | 1.05% |
| 23-03-17 | China Monthly Antitrust Update - March 2023 | AQ |
| 1 day | +1.21% | ||
| 1 week | +6.12% | ||
| Current month | +9.83% | ||
| 1 month | +2.65% | ||
| 3 months | +3.07% | ||
| 6 months | -1.95% | ||
| Current year | -3.64% |
| 1 week | 4.75 |  | 5.13 |
| 1 month | 4.47 | | 5.13 |
| Current year | 4.09 | | 5.73 |
| 1 year | 4.09 | | 5.98 |
| 3 years | 3.72 | | 6.69 |
| 5 years | 3.72 | | 9.3 |
| 10 years | 3.72 | | 9.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Gang Cai
CEO | Chief Executive Officer | 46 | 2025-01-20 |
Xin Li
DFI | Director of Finance/CFO | 46 | 2025-09-05 |
Dong Sheng Yan
IRC | Investor Relations Contact | 42 | 2024-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Kai Zhou
CHM | Chairman | 62 | 2025-01-20 |
Xin Hua Ao
BRD | Director/Board Member | 62 | 2018-07-17 |
Cheng Ren Huang
BRD | Director/Board Member | 62 | 2018-07-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.21% | +6.12% | -14.02% | -8.04% | 1.06B | |
| -2.25% | -0.47% | +68.30% | +116.05% | 1,052B | |
| -0.66% | +0.43% | +47.39% | +51.02% | 627B | |
| -0.54% | +1.39% | +20.69% | +64.61% | 441B | |
| -1.99% | -3.32% | +38.71% | +36.26% | 349B | |
| -1.05% | -2.81% | +23.07% | +35.91% | 287B | |
| -2.12% | -3.67% | -1.14% | +5.35% | 241B | |
| -0.63% | +1.04% | +40.05% | +56.67% | 224B | |
| -1.19% | -3.41% | -9.57% | -53.50% | 202B | |
| +0.16% | +3.87% | +16.89% | +77.38% | 172B | |
| Average | -0.91% | +0.74% | +23.04% | +38.17% | 359.62B | |
| Weighted average by Cap. | -1.36% | +0.05% | +39.07% | +61.74% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.5B 1.11B 961M 903M 821M 1.54B 106B 1.57B 10.58B 4.14B 53.27B 4.18B 4.09B 177B | 7.07B 1.05B 906M 851M 774M 1.46B 100B 1.48B 9.98B 3.9B 50.23B 3.94B 3.85B 167B |
| Net income | 410M 60.77M 52.48M 49.32M 44.85M 84.33M 5.81B 85.72M 578M 226M 2.91B 228M 223M 9.67B | 260M 38.56M 33.3M 31.3M 28.46M 53.51M 3.69B 54.39M 367M 143M 1.85B 145M 142M 6.14B |
| Net Debt | -2.88B -426M -368M -346M -315M -592M -40.77B -601M -4.05B -1.59B -20.42B -1.6B -1.57B -67.85B | -1.49B -221M -191M -179M -163M -307M -21.13B -312M -2.1B -822M -10.58B -830M -812M -35.17B |
Employees
5,727
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | CN¥5.030 | +1.21% | 26,294,714 |
| 26-08-13 | CN¥4.970 | +1.22% | 36,164,406 |
| 26-08-12 | CN¥4.910 | +1.66% | 18,697,009 |
| 26-08-11 | CN¥4.830 | +0.84% | 16,977,041 |
| 26-08-10 | CN¥4.790 | +1.05% | 15,076,093 |
- Stock Market
- Stocks
- 000597 Stock
Select your edition
All financial news and data tailored to specific country editions
